"Where Everyone Has an MBA"
Tel: (612) 246-4616
Frequently Asked Questions
- Frequently Asked Questions
- User Testimonials
Alnylam Pharmaceuticals, Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Alnylam Pharmaceuticals, Inc.
Alnylam to Webcast Conference Call Discussing Third Quarter 2020 Financial Results
- Oct 22nd, 2020 8:00 pm
Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?
- Oct 22nd, 2020 4:33 pm
Alnylam Presents Positive Results from ILLUMINATE-B Phase 3 Study in Pediatric Patients with Primary Hyperoxaluria Type 1 at the American Society of Nephrology Kidney Week
- Oct 22nd, 2020 2:00 pm
Is Ionis Pharmaceuticals a Buy?
- Oct 19th, 2020 4:46 pm
Alnylam (ALNY) Gets Positive CHMP Opinion for Lumasiran
- Oct 19th, 2020 1:55 pm
Can Either of These Little-Known Biotechs Find New Life Fighting Coronavirus?
- Oct 18th, 2020 10:43 am
Alnylam Receives Positive CHMP Opinion for OXLUMO™ (lumasiran) for the Treatment of Primary Hyperoxaluria Type 1 in All Age Groups
- Oct 16th, 2020 10:00 am
Vertex Tumbles As It Stops Testing On Protein Deficiency Treatment
- Oct 15th, 2020 8:12 pm
When Will Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Turn A Profit?
- Oct 11th, 2020 12:33 pm
Alnylam Releases Positive Top-Line Rare Disease Lumasiran Data
- Oct 1st, 2020 2:50 pm
Alnylam Pharmaceuticals Posts Positive Results For Its Treatment For Rare Disease
- Sep 30th, 2020 8:19 pm
Alnylam Reports Positive Topline Results from ILLUMINATE-B Phase 3 Study of Lumasiran for the Treatment of Primary Hyperoxaluria Type 1 in Children Under the Age of Six
- Sep 30th, 2020 11:00 am
Alnylam to Webcast Presentation at Chardan Virtual 4th Annual Genetic Medicines Conference
- Sep 28th, 2020 8:00 pm
Arrowhead Pharma Reveals Positive Data On Drug To Treat Liver Disease; ARWR Stock Jumps
- Sep 16th, 2020 8:24 pm
Hedge Funds Have Never Been This Bullish On Alnylam Pharmaceuticals, Inc. (ALNY)
- Sep 10th, 2020 1:47 am
3 Healthcare Stocks I Can't Wait to Buy When the Stock Market Tanks Again
- Sep 9th, 2020 10:29 am
Why Is Alnylam (ALNY) Down 14.8% Since Last Earnings Report?
- Sep 5th, 2020 3:32 pm
Alnylam Highlights Prospects for Building an Industry-Leading ATTR Amyloidosis Franchise at RNAi Roundtable
- Sep 3rd, 2020 11:30 am
Alnylam to Webcast Presentations at Upcoming September Investor Conferences
- Sep 2nd, 2020 12:00 pm
Alnylam's Share Price Rises YTD on Pipeline Developments
- Aug 27th, 2020 2:17 pm
Frequently Asked Questions
Terms and Conditions
Copyright © 2020 VentureLine
Website developed by Digital Solutions